Call for tenders (HaDEA): Framework contracts to speed up the development of and access to next-generation therapeutics for infectious diseases

From the official press release:

"This call for tenders aims to speed up the development of promising next-generation therapeutics for infectious diseases by adopting a competitive development in phases under pre-commercial procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, acute respiratory distress syndrome (ARDS) or sepsis resulting from infections.

The call for tenders is divided into two lots:

• Highly innovative therapeutics;
• Advanced therapeutics.

This action supports the policy priority to enhance the availability and accessibility of medical countermeasures and critical medicines, to support innovation and access regarding such products and to ultimately enhance preparedness for future health emergencies. It also implements the EU4Health programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices and crisis-relevant products.

Total budget: € 252 000 000.

Interested parties are invited to request their participation via the EU Funding and Tenders Portal by 2 September 2026, 16.00 (CEST)."